Editorial governance

Editorial Team

Pharminsight is an open-access platform for expert perspectives, opinions, white papers, case studies, and translational insights from professionals across pharmaceuticals, biotechnology, healthcare, regulatory sciences, manufacturing, investment, and innovation ecosystems.

Pharminsight is not a scientific journal. Submissions are evaluated for relevance, originality, clarity, practical impact, and quality of insight rather than academic novelty alone.

Super Admin

Prathamesh

Designation: Developer

Full Stack Web Developer And IT Associate

Author Guidelines

Types of contributions

Perspective Articles

Expert viewpoints on emerging technologies, industry trends, regulatory developments, scientific challenges, manufacturing strategies, market evolution, or future opportunities.

1,000-2,000 words

Opinion Articles

Thought-provoking commentary on current issues affecting the pharmaceutical and biotechnology sectors.

800-1,500 words

White Papers

Comprehensive analyses of strategic, scientific, technical, regulatory, manufacturing, or policy-related topics.

2,000-5,000 words

Industry Problem Statements

Description of a significant industry challenge together with proposed solutions, frameworks, or recommendations.

1,000-2,500 words

Case Studies

Lessons learned from product development, technology implementation, process optimization, regulatory submissions, commercialization, or organizational transformation.

1,500-3,000 words

Submission requirements

Clear and concise title
Author information: full name, designation, organization, country, email, and optional LinkedIn profile
Abstract of 100-200 words summarizing the key message
3-8 keywords
Main content organized with headings and subheadings
3-5 concise key takeaways
References to literature, reports, regulations, guidance documents, or credible sources where appropriate

Content expectations

Encouraged

· Share practical experiences
· Present evidence-based opinions
· Highlight lessons learned
· Discuss challenges and opportunities
· Propose solutions and recommendations
· Offer future outlooks

Discouraged

Promotional content
Product marketing
Excessive corporate branding
Literature summaries without original insight
AI-generated generic content lacking expert interpretation
Confidential or proprietary information

Reviewer Guidelines

Purpose and evaluation criteria

Reviewers help maintain quality, credibility, and relevance. Unlike traditional scientific journals, reviewers assess submissions primarily for practical value, accuracy, originality of thought, and industry relevance.

Relevance

Does the topic address a significant issue for industry, academia, startups, regulators, investors, or healthcare stakeholders?

Originality

Does the article contribute new insights, practical experiences, frameworks, or perspectives?

Technical Accuracy

Are technical claims supported by evidence, established practice, or credible references?

Practical Impact

Will readers gain meaningful knowledge that can influence decision-making, strategy, policy, or implementation?

Clarity

Is the content organized logically and written in a clear, concise manner?

Balance

Are opposing viewpoints acknowledged where appropriate?

Recommendations

Accept, Minor Revision, Major Revision, or Reject.

Confidentiality

Submissions must not be shared, reused, or discussed outside the review process.

Review Timeline

Reviews are requested within 14 days of assignment unless otherwise agreed.

Disclosure and Transparency

Authors must disclose employment affiliations, consulting relationships, financial interests, sponsorships, and potential conflicts of interest. The editorial team may request additional disclosures when necessary.

Publication and Copyright

Authors retain ownership of their original work while granting Pharminsight the right to publish, distribute, archive, and promote the content. Substantive changes are communicated before publication.

AI-Assisted Writing

Authors may use AI-assisted tools for language improvement and drafting support, but remain fully responsible for accuracy. Fabricated references, data, or claims are strictly prohibited.

Code of Conduct

Pharminsight promotes respectful, evidence-based, and constructive dialogue. Offensive, discriminatory, defamatory, misleading, or unethical content will not be considered.

Editorial philosophy

Practical wisdom with editorial rigor

We value practical wisdom as much as scientific rigor. The most impactful submissions combine technical expertise, real-world experience, and actionable recommendations that help move the life sciences ecosystem forward.